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WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT 
 
 Obesity has been highlighted as one of the major public health challenges facing the 
UK in the 21st Century. 
 There is insufficient evidence to recommend the provision of structured weight 
management interventions via general practitioner practices or community 
pharmacies. 
 
WHAT THIS STUDY ADDS 
 
 The My Choice Weight Management Programme, delivered via general practitioner 
practices and community pharmacies in one city of the UK, produced modest 
reductions in weight. 
 Such programmes alone are unlikely to be sufficient to combat the obesity epidemic. 
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ABSTRACT 
 
Objective: To assess the effectiveness of a novel, community-based weight management 
programme delivered through general practitioner (GP) practices and community 
pharmacies in one city in the United Kingdom. 
Design: Non-randomised, retrospective, observational comparison of clinical data collected 
by participating GP practices and community pharmacies. 
Subjects: 451 overweight or obese men and women resident in areas of high 
socioeconomic deprivation (82% from black and minority ethnic groups, 86% female, mean 
age: 41.1 years, mean BMI: 34.5 kg/m2). 
Measurements: Weight, waist circumference and BMI at baseline, after 12 weeks and after 
9 months. Costs of delivery were also analysed. 
Results: Sixty-four per cent of participants lost weight after the first twelve weeks of the My 
Choice Weight Management Programme. There was considerable drop-out. Mean 
percentage weight loss (last observation carried forward) was 1.9% at 12 weeks and 1.9% at 
final follow-up (9 months). There was no significant difference in weight loss between 
participants attending GP practices and those attending pharmacies at both twelve weeks 
and at final follow-up. Costs per participant were higher via community pharmacy which was 
attributable to better attendance at sessions amongst community pharmacy participants than 
amongst GP participants. 
Conclusion: The My Choice Weight Management Programme produced modest reductions 
in weight at 12 weeks and 9 months. Such programmes may not be sufficient to tackle the 
obesity epidemic.  
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INTRODUCTION 
 
Obesity is a significant health and social problem that has reached pandemic levels. Several 
prospective studies have demonstrated the relationship between obesity and premature 
death from coronary heart disease, cancers and other diseases as well as psychosocial 
problems, such as negative self-esteem, social withdrawal and discrimination.1-5 
 
Obesity now presents as one of the largest health problems facing the UK today and has 
been highlighted as one of the major public health challenges facing the UK in the 21st 
Century.6-8 In the 20 years to 2001, the prevalence of obesity tripled.9 Based on current 
trends, it is estimated that by 2050 over half of the UK adult population could be obese 
costing the NHS £9.7 billion and, when higher rates of sickness absence from work 
associated with being obese, and reduced productivity and overall costs to business are 
taken into account, £49.9 billion to society as a whole.10 
 
There is a paucity of evidence on the effectiveness of both general practice (GP)-led and 
pharmacy-led weight management interventions. UK National Institute for Health and Care 
Excellence (NICE) guidance on obesity highlights that the identified evidence did not appear 
to suggest that the health professional who provides advice and support was important, the 
key issues being whether the health professional is motivational and the maintenance of 
support to the patient.11 
 
One randomised controlled trial of a nurse-led, general practice-based weight management 
programme for individuals with a BMI of ≥27 kg/m2 reported that, at 12 weeks, 34% of 
participants in the intervention arms of the trial lost at least 5% of their initial weight 
compared to 19% in the usual care arms.12 In the Counterweight Project, 31% and 32% of 
participants respectively had maintained a weight loss of at least 5% of initial weight at 12 
and 24 months respectively while in a randomised controlled trial of a primary care-based 
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weight management intervention, delivered by physicians and tailored to the needs of 144 
obese, low-income, African-American women in the US, 13% of participants remaining in the 
intervention arm at six months lost 5% of their initial weight compared to 5% of participants 
remaining in the control arm.13-15 However, other GP-based interventions have proven less 
successful in reducing the weight of obese patients.16 
 
Pharmacy involvement in tackling obesity in the UK has been limited to date but with the 
high priority now afforded to tackling the obesity epidemic, the community pharmacy-based 
provision of weight management services is likely to be given increasing consideration by 
commissioners of health services. Available data on the effectiveness of such services are 
largely absent but a service delivered by community pharmacies in Scotland produced 
weight loss amongst 458 participants of 1.3 kg at 12 weeks and 1.7 kg at one-year follow-up 
(using last observation carried forward). Ten per cent and 16% of participants achieved the 
target weight loss of 5% at 12 weeks and one year respectively.17 
 
While community pharmacy-based provision of weight management services has been 
limited in the UK, a number of studies have been conducted elsewhere. In a randomised 
controlled open-label trial conducted in a single community pharmacy in the United States 
the efficacy of a meal replacement programme (Slim-Fast®) was compared to the efficacy of 
a conventional reduced calorie diet.18 Participants in both arms of the trial attended 
consultations with a pharmacist every two weeks where advice and counselling were 
provided. Statistically significant weight loss was observed in both arms of the trial at 10 
sessions (mean weight loss was 4.9 kg in the intervention arm and 4.3 kg in the control arm) 
with no significant difference in weight loss between the two arms. In total forty-one per cent 
of participants lost at least 5% of their initial weight at 22 sessions. A further study conducted 
in a single, university campus pharmaceutical care centre in the USA assessing the 
effectiveness of pharmacist education and counselling (and in some cases counselling plus 
pharmacotherapy) produced mean weight loss of 3.6 kg.19 Interventions in Denmark and 
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Switzerland have also demonstrated the effectiveness of community pharmacy based weight 
management interventions.20 21 
 
A 2011 article in the British Medical Journal assessed the effectiveness of the delivery of 
weight management programmes via various primary care- or community-based providers.22 
The Lighten Up randomised controlled trial compared commercial and primary care led 
weight reduction programmes. In total, 740 overweight or obese participants were randomly 
assigned to one of three commercial weight loss programmes (Weight Watchers®, Slimming 
World®, Rosemary Conley®), a group-based, dietetics-led programme delivered in the 
community, general practice led one-to-one counselling, pharmacy led one-to-one 
counselling, a choice of any of these six programmes or a comparator group which received 
12 vouchers enabling free entrance to a local leisure centre. Mean weight loss at twelve 
weeks was 2.1 kg in the pharmacy arm and 1.4 kg in the GP arm. Among participants 
followed up at one year weight loss was marginally greater in GPs (0.8 kg) than in 
pharmacies (0.6 kg). Weight loss was greater in commercial organisations than in primary 
care providers, a phenomenon also observed in the trial reported by Jebb et al (2011).23 
 
The Lighten Up trial was a welcome addition to the evidence base concerning GP- and 
pharmacy-based weight management services as data comparing the effectiveness of 
providers in delivering such services is particularly lacking. In this manuscript an evaluation 
of a novel, community-based weight management programme (the My Choice Weight 
Management Programme) – delivered via GPs and community pharmacists in one city in the 
United Kingdom – is presented.  
 
MATERIALS AND METHODS 
 
While most primary care based weight management interventions have been delivered 
through a single type of care provider, the My Choice Weight Management Programme was 
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designed to operate from both community pharmacies and the practices of GPs contracted 
to provide services by Heart of Birmingham teaching Primary Care Trust (HoBtPCT – at the 
time, the local National Health Service (NHS) primary care organisation responsible for the 
provision of primary care services to approximately 300,000 residents of central 
Birmingham). The programme was targeted at individuals who were ‘ready to change’ 
(analogous to the ‘preparation’ stage of the Transtheoretical Model of Health Behaviour 
Change) and enabled individuals to work with a trained health worker (for example, a health 
care assistant, practice nurse or pharmacy assistant) in an attempt to reduce weight via 
lifestyle modification.24 
 
Participants on the programme were helped to develop a care plan with the aim of a 5-10% 
reduction in body weight at completion of the programme. The My Choice Weight 
Management Programme also aimed to reduce adult obesity levels, improve access to 
overweight and obesity management services in primary care, improve diet and nutrition, 
promote healthy weight and increased levels of physical activity in overweight or obese 
patients, and support patients to make lifestyle changes to enable them to lose weight. 
 
Twelve pharmacies and twelve GP practices were recruited to deliver the service, free-of-
charge to participants, via service level agreements with HoBtPCT. Providers of the 
programme were responsible for the recruitment of participants over the course of the 
programme (up to a maximum of 30 participants per provider). Participants were recruited 
according to the following criteria: 
 
 Aged 18 years or over and had a BMI: 
o Greater than 30 kg/m2 (greater than 25 kg/m2 in South Asians1)  
                                                          
1people with ancestral links to Bangladesh, India, Nepal, Pakistan or Sri Lanka 
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o Greater than 28 kg/m2 (greater than 23.5 kg/m2 in South Asiansa) with one or 
more of the following co-morbidities (diabetes, hypertension, cardiovascular 
disease). 
 
Each participant was scheduled to attend weekly following recruitment – an initial baseline 
consultation followed by eleven weekly consultations (the last of these weekly sessions is 
hereafter referred to as ‘session 12’). Participants were also offered up to three follow-up 
appointments, to take place every 2 months for up to 6 months after completion of session 
12 (the last of these three follow-ups – taking place at approximately nine months post-
recruitment is hereafter referred to as ‘session 15’). 
 
The following data were collected by providers from participants at baseline: 
 
 Date of consultation 
 Sex 
 Age (in years) 
 Postcode 
 Self-reported ethnicity 
 Height (m) 
 Weight (kg) 
 Waist circumference. 
 
The collection of participants’ height and weight allowed for the calculation of each 
participant’s body mass index (BMI). To provide an indication of the level of socioeconomic 
deprivation in the geographical area where the participant resided, the Indices of Multiple 
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Deprivation (IMD) 2010 score2 for the Lower Layer Super Output Area (LSOA)3 
corresponding to the participants’ postcodes were added to the dataset using data linking 
postcode to LSOA available in the UKBorders dataset.25-27  
 
At all subsequent sessions, the following data were collected: 
 
 Date of consultation 
 Weight (kg) 
 Waist circumference. 
 
Data were recorded routinely at each appointment using pre-designed data collection forms. 
The analysis is therefore dependent on the volume and accuracy of the collected data. 
Payment to providers was based on the submission of completed data collection forms. 
While non-submission of forms was a possibility, the financial incentive applied to their 
submission makes this unlikely.  
 
In addition to this monitoring, in conjunction with a member of staff at their provider, 
participants were set ‘realistic’ weight loss targets (a weekly weight loss of 0.5-1 kg per 
session with the aim of losing 5-10% of original weight by session 12) and lifestyle, 
behaviour, diet and activity were also assessed. Participants were also encouraged to keep 
a food and exercise diary and to modify lifestyle, diet and physical activity appropriately. To 
meet these ends, a different topic was covered at each appointment with the participants 
being provided with supporting written material (in the form of leaflets etc.). Both the topics 
                                                          
2 The IMD combine a number of indicators, chosen to cover a range of socioeconomic issues, into a 
single deprivation score for each Super Output Area (Lower Layer and Middle Layer) in England. The 
higher the IMD 2010 score, the more deprived an area is. 
3 Super Output Areas (SOAs), are a geography designed for the collection and publication of small 
area statistics. There are currently two levels of SOA – Lower Layer SOAs (LSOAs) which divide 
England into 34,378 areas with a mean number of residents of 1,500 in each area and Middle Layer 
SOAs (MSOAs) which divide England into 7,193 areas with a mean number of residents of 7,200 in 
each. 
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covered and the written materials were tailored towards meeting the needs of the local 
population (70% of the resident population of HoBtPCT were from black and minority ethnic 
groups).28 The schedule for session 1 to 12 was as follows (further detail on the programme 
can be found in the accompanying appendix): 
 
 Session 1: Assessment 
 Session 2: Healthy eating 
 Sessions 3-11 covered following topics. The topics could be covered in any order 
with the order they were covered in being decided by the provider in conjunction with 
the participant: 
o Being more active 
o Coping with slip-ups and setbacks 
o Drinks 
o Eating frequency and snacking 
o Hunger and emotional eating 
o Planning ahead 
o Portion Control 
o Special Occasions 
o Support and Rewards 
o Understanding food labels 
 Session 12: Maintaining weight loss. 
 
The primary outcome was weight loss at session 12. Secondary outcomes were weight loss 
at session 15, proportion of participants losing ≥5% of body weight at sessions 12 and 15 
and weight loss (or gain) between session 12 and session 15. Data on outcomes are 
presented both for ‘completers’ (i.e. participants attending session 12 and/or session 15) 
and, where these data were not available, on an intention-to-treat basis with missing values 
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imputed via last observation carried forward (LOCF). Attendance rates and costs data are 
also reported. Microsoft Excel 2010® (Microsoft Corporation, Redmond, WA, USA) was 
used for data analysis with some additional analysis being undertaken in SPSS v16.0® 
(SPSS Inc., Chicago, IL, USA). Descriptive statistics are presented both for all participants 
and by provider type. To determine whether there were relationships between variables the 
following statistical tests were applied to the data: 
 Where categorical data is detailed, the chi-squared test of association was used. 
 When comparing the means of two samples, an unpaired- t-test was used. 
 
RESULTS 
 
A total of 451 individuals were recruited to the programme (i.e. attended at least one 
session). GP providers (n=268) recruited more participants than pharmacy providers 
(n=183). Overall, 86% of participants were female and the mean age of the cohort was 41 
years. 
 
There was no statistically significant difference between the IMD 2010 score of the LSOA 
corresponding to the participants’ postcode between pharmacy participants and GP 
participants. However there were statistically significant differences between participants 
attending pharmacies and participants attending GPs with GP participants tending to be 
older than their pharmacy counterparts. Additionally, the ethnic composition of the two 
groups differed significantly (see Table 1). 
 
Attendance 
 
The mean number of sessions attended per participant in the programme was seven. Thirty 
seven per cent of participants attended the first twelve sessions and less than one-in-five 
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participants attended all 15 available sessions. Attendance was uniformly better at pharmacy 
providers than at GP providers (see Table 2). There were no statistically significant 
differences between the demographic characteristics of participants at baseline and those 
completing session 12.  
 
Weight and waist circumference data 
 
At baseline, there was considerable heterogeneity in weight, BMI and waist circumference 
between participants recruited through pharmacies and those recruited through GP 
practices. Participants recruited at GP practices were heavier and had larger BMIs and waist 
circumferences. While 30% of participants recruited at pharmacies had a BMI of 35 or more, 
this proportion was almost 50% amongst participants recruited at GP practices (see Table 
3).  
 
At session 12, 64% (n=289/451) of enrolled participants had lost weight. This proportion 
increased to eighty-five per cent (n=141/166) amongst completers (participants who 
attended session 12). Mean percentage weight loss was 1.9% (3.3% amongst completers). 
Completers attending GP practices lost more weight during the first twelve sessions than 
those attending pharmacies (4.0% and 2.8% respectively; p<0.05). Fourteen per cent 
(n=64/451) of participants achieved a reduction in weight of 5% or more with no significant 
difference between providers (see Table 4). There were no statistically significant 
relationships between sex, age, IMD quintile or ethnicity and percentage weight loss at 
session 12.  
 
There was no significant difference in weight loss between providers at session 15 although 
weight loss was greater in participants attending pharmacies than in participants attending 
GPs (see Table 4). When considering weight loss between session 12 and session 15, it is 
apparent that GP participants failed to maintain their weight status achieved at session 12 
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(recording a mean weight gain of 0.9%) whereas participants attending pharmacies 
continued to lose weight between session 12 and session 15 (a mean weight loss of 1.2%). 
This difference was statistically significant. However, the small numbers of participants 
attending session 15 (pharmacy n=60, GP n=23) should be noted. 
 
Costs of providing the service 
 
Table 5 shows the costs of delivering the programme. As the majority of payments were 
based on the number of sessions hosted and GP providers recruited more participants than 
pharmacy providers, total costs were higher for GP providers than for pharmacy providers. 
Costs per participant were higher through pharmacies than through GPs. This was true 
throughout the course of the programme but the gap in costs between pharmacy and GP 
providers narrowed as participants continued through the programme to the point where 
there was no statistically significant difference in costs between providers among 
participants attending session 15. Again, this is a result of the larger number of participants 
recruited by GPs (thus allowing for distribution of, for example, training costs across a larger 
pool of participants). However, when controlling for the number of sessions hosted (mean 
number of sessions attended by participants: pharmacy=7.9; GP=6.5) pharmacy provision 
cost less per participant than GP provision (£19.80 per session versus £20.30 per session). 
 
Similarly costs per 1% of weight loss were £87.00 among pharmacy providers and £59.00 at 
GP providers (£74.30 combined) at session 12. Among participants attending session 15, 
the opposite pattern was observed with costs being lower among pharmacy providers than 
GP providers for both measures (although these differences were not statistically 
significant).  
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DISCUSSION 
 
Four hundred and fifty one participants were recruited to the My Choice Weight Management 
Programme. GP providers recruited more participants than pharmacy providers. Females 
were over-represented in the cohort although this appears to be consistent with other 
community- or primary care-based services; particularly those delivered through community 
pharmacy.18 29 30 Eighty two per cent (GP 81%; pharmacy 87%) of participants were from 
black and minority ethnic groups, the mean age of participants was 41 years (GP 42.6 years; 
pharmacy 38.9 years) and participants predominantly resided in areas of high 
socioeconomic deprivation (mean IMD score=43.6: GP 43.8; pharmacy 43.3). While 
comparative data is hard to come by, the demographic characteristics of the participants in 
this programme may make this cohort unique and make direct comparison with results from 
other studies problematic. For example, in the GP and pharmacy arms of the Lighten Up 
trial, hosted in the neighbouring South Birmingham PCT, 10% and 13% of participants 
respectively were from black and minority ethnic groups, mean age was 50.5 years and 48.9 
years respectively and mean IMD scores were 32.2 and 35.1 respectively.22  
 
GP participants were older, less likely to self-define their ethnicity as Asian, heavier and had 
higher BMIs at baseline than pharmacy participants.  It has been reported that individuals 
with higher BMI categories are more likely to report large decreases in weight then 
individuals with lower BMI categories.31 32 The heterogeneity between GP and pharmacy 
participants should be noted when interpreting the results. 
 
Almost two-thirds of participants enrolled on the My Choice Weight Management 
Programme lost weight at session 12. The reductions in weight seen in the programme at 
twelve weeks were broadly similar with those observed in the GP and pharmacy arms at the 
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same stage of the Lighten Up trial.22 Weight loss and BMI reduction was higher among GP 
completers than pharmacy completers.  
 
One of the principal targets for participants in the My Choice Weight Management 
Programme was to lose 5-10% of their initial weight. Fourteen per cent of participants 
achieved a reduction in weight of 5% or more with no difference in performance between 
providers. The proportion of participants on the programme achieving a weight loss of at 
least 5% by session 12 is lower than that observed in the GP and pharmacy arms of the 
Lighten Up trial while the proportion of pharmacy participants who achieved a reduction in 
weight of 5% or more was higher than that reported by Morrison et al.17 22 There were no 
statistically significant relationships between sex, age, IMD quintile or ethnicity and weight 
loss at session 12. 
 
Completers attending the My Choice Weight Management Programme at pharmacies 
appeared to be more successful at maintaining weight loss after completion of session 12 
than completers attending at GPs. At session 15, weight loss (both absolute and as a 
percentage value) and BMI reduction was higher among pharmacy completers than GP 
completers. Indeed, completers at GP practices tended to gain weight between sessions 12 
and 15. Among participants attending both session 12 and 15, pharmacy participants 
continued to lose weight whereas GP participants gained weight. 
 
The mean weight loss achieved by participants at session 15 (approximately 9 months) is of 
a similar quantum to that achieved in other programmes at one year.22 33 Mean weight loss in 
pharmacy participants at session 15 (2.0 kg) was similar to that reported by Morrison et al 
(LOCF) at one year (1.7 kg).17 The mean weight loss achieved among GP completers at 
session 15 (9% of participants, n=23/268; weight loss 2.3 kg) is slightly less than that seen 
at one year follow up in the Counterweight Project (34% of participants, n=642/1906; weight 
loss 3.0 kg).14 
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Participant dropout was relatively common in the programme with less than half of recruited 
participants going on to complete the programme. High levels of participant dropout have 
been highlighted as a recurring feature of pharmacy-based weight management services 
and only 50% of pharmacy participants on the My Choice Weight Management Programme 
attended session 12.17-19 29 However, it should be noted that attendance rates on the 
programme were better at pharmacies than at GP providers. The demographic 
characteristics of participants had no discernible impact on completion rates. 
 
The total cost of delivering the My Choice Weight Management Programme was £50,200. 
Total costs were higher among GP providers than among pharmacy providers. Costs per 
participant and per completing participant were higher through pharmacies than through 
GPs. This is a result of the larger number of participants recruited by GPs (thus allowing for 
distribution of, for example, training costs across a larger pool of participants) and the lower 
rates of attendance observed among GP participants. These costs are broadly similar for 
those reported for pharmacy and GP providers in the Lighten Up trial although it should be 
noted that the figures from Lighten Up do not include any training costs for providers, are 
calculated for a standard pool size of 70 participants and that recruitment in the trial was 
organised by a central call centre.22 When controlling for the number of sessions hosted, 
costs were broadly similar with pharmacy provision costing slightly less per participant than 
GP provision.  Costs per 1% of weight loss during the programme were higher amongst 
pharmacy completers than amongst GP completers at session 12. At final-follow-up, costs 
per 1% weight loss were higher amongst GP completers than amongst pharmacy 
completers although this difference was not statistically significant. 
 
The My Choice Weight Management Programme demonstrated similar levels of 
effectiveness to other primary care based weight management programmes. Reductions in 
weight loss at 12 weeks were modest but were maintained in a significant proportion of the 
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cohort when assessed at final follow-up (approximately 9 months after recruitment in to the 
programme). Amongst participants attending the first 12 weeks of the programme, weight 
loss was greater among participants attending the programme at GP practices than among 
participants attending the programme at a community pharmacy. However, pharmacy 
completers were more likely than GP completers to maintain, and indeed increase weight 
loss between week 12 and final follow-up.  
 
Given the modest levels of effectiveness observed, allied to weight gain in some participants 
between week 12 and final follow-up and the not inconsiderable costs incurred in provision 
of the programme, this study adds weight to the argument that individual-level, primary care 
interventions are unlikely to prove effective or cost-effective in combating the problems 
posed by obesity.33 The difficulty in inducing weight loss amongst a cohort with unique 
demographic characteristics – My Choice Weight Management Programme participants 
were recruited from areas with high levels of socioeconomic deprivation and over four-fifths 
of participants were from Black and Minority Ethnic groups; populations which are 
traditionally underserved by healthcare interventions – suggests that population-level 
interventions, including changes to government policy, are likely to be necessary to tackle 
the obesity epidemic. 
 
The case for further investigation of the My Choice Weight Management Programme is not 
compelling but may be desirable given the atypical (in the context of the wider UK 
population) nature of the cohort examined. Any future research should examine whether the 
intervention is replicable in a larger cohort, over a longer period of time and attempt to 
account for any possible sampling bias and reduce the possibility of confounding via 
randomisation of participants to distinct control and intervention arms. Given reports of 
weight gain between cessation of intensive intervention and follow-up sessions in 
community-based weight management interventions, future assessments of such 
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interventions should consider greatly extending follow-up periods or even leaving follow-up 
periods open so that interventions have no pre-defined end point.14 16 22  
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TABLES 
 
Table 1: Characteristics of participants at baseline by provider type. Figures are numbers 
(percentages) unless otherwise stated. 
Characteristics Combined GP Pharmacy p-value 
Participants 451 (100.0) 268 (59.4) 183 (40.6) - 
Male sex 65 (14.4) 41 (15.3) 24 (13.1) 0.517 
Mean (SD) age (years) 41.1 (12.4) 42.6 (11.8) 38.9 (13.0) 0.002 
Mean (SD) IMD 2010 43.6 (15.0) 43.8 (15.8) 43.3 (13.8) 0.703 
Ethnic group 
<0.0011 
Asian 231 (51.2) 117 (43.7) 114 (62.3) 
Black 116 (25.7) 74 (27.6) 42 (23.0) 
Mixed 20 (4.4) 17 (6.3) 3 (1.6) 
White 77 (17.1) 53 (19.8) 24 (13.1) 
Other 3 (0.7) 3 (1.1)  
Missing 4 (0.9) 4 (1.5)  
 
1‘other’ and ‘missing’ categories excluded 
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Table 2: Attendance at sessions in the My Choice Programme by provider type. Figures are 
numbers (percentages) unless otherwise stated. 
Attendance measure Combined GP Pharmacy p-value 
Total number of sessions attended by all participants 3182 (58.8) 1735 (53.9) 1447 (65.9) - 
Mean number (SD) of sessions attended per participant 7.0 (4.4) 6.5 (4.2) 7.9 (4.5) <0.001 
Participants attending session 12 (% recruited participants) 167 (37.0) 75 (28) 92 (50) <0.001 
Participants attending session 15 (% recruited participants) 83 (18.4) 23 (9) 60 (33) <0.001 
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Table 3: Baseline measurement data by provider type. Figures are numbers (percentages) 
unless otherwise stated. 
Measurement Combined 
(n=451) 
GP (n=268) Pharmacy 
(n=186) 
p-
value 
Mean (SD) starting weight (kg) 91.9 (18.5) 95.8 (18.4) 86.1 (17.1) <0.001 
Mean (SD) starting BMI (kg/m2)1 34.5 (5.7) 35.6 (5.6) 33.0 (5.6) <0.001 
Mean (SD) starting waist circumference 
(cm)2 
107.3 (13.9) 108.8 
(14.1) 
105.1 (13.4) 
0.004 
Starting BMI (kg/m2)  
<0.001 
<30 79 (17.7) 27 (10.2) 52 (28.6) 
30-34 182 (40.7) 107 (40.4) 75 (41.2) 
35-39 105 (23.5) 76 (28.7) 29 (15.9) 
≥40 81 (18.1) 55 (20.8) 26 (14.3) 
 
1n=447 owing to missing/erroneous recording of participants’ height 
2n=444 owing to missing values 
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Table 4: Participant outcomes at session 12 and session 15 by provider type. Figures are 
numbers (percentages) unless otherwise stated. 
Outcomes Combined GP Pharmacy p-value 
Session 12 
Mean weight loss (95% CI) (kg) 
Completers1 3.0 (±0.5) 3.8 (±0.8) 2.4 (±0.6) 0.007 
LOCF2 1.7 (±0.3) 1.8 (±0.4) 1.6 (±0.4) 0.549 
Mean percentage weight loss 
(95% CI) 
Completers 3.3 (±0.5) 4.0 (±0.9) 2.8 (±0.7) 0.031 
LOCF 1.9 (±0.3) 1.8 (±0.4) 1.9 (±0.4) 0.875 
Percentage weight loss 
C3=0.328 
L4=0.080 
No change/ weight gain 
Completers 25 (15.1) 11 (14.7) 14 (15.4) 
LOCF 162 (35.9) 
107 
(39.9) 
55 (30.1) 
0.1%-4.9% 
Completers 95 (57.2) 39 (52.0) 56 (61.5) 
LOCF 225 (49.9) 
123 
(45.9) 
102 (55.7) 
≥5% 
Completers 46 (27.7) 25 (33.3) 21 (23.1) 
LOCF 64 (14.2) 38 (14.2) 26 (14.2) 
Mean reduction (95% CI) in BMI 
(kg/m2)  
Completers 1.1 (±0.2) 1.4 (±0.3) 0.9 (±0.2) 0.006 
LOCF 0.6 (±0.1) 0.6 (±0.1) 0.7 (±0.2) 0.586 
Mean reduction (95% CI) in waist 
circumference (cm) 
Completers 5.4 (±0.8) 6.0 (±1.3) 4.9 (±0.9) 0.186 
LOCF 3.9 (±0.9) 4.1 (±1.5) 3.6 (±0.7) 0.578 
 
Session 15 
Mean weight loss (95% CI) (kg) 
Completers5 3.1 (±0.9) 2.3 (±1.9) 3.4 (±1.1) 0.324 
LOCF2 1.9 (±0.3) 1.8 (±0.4) 2.0 (±0.5) 0.507 
Mean percentage weight loss 
(95% CI) 
Completers 3.5 (±1.1) 2.2 (±1.9) 4.0 (±1.3) 0.131 
LOCF 2.0 (±0.3) 1.8 (±0.4) 2.3 (±0.6) 0.161 
Percentage weight loss 
C=0.062 
L=0.029 
No change/ weight gain 
Completers 21 (25.6) 8 (36.4) 13 (21.7) 
LOCF 171 (37.9) 
113 
(42.2) 
58 (31.7) 
0.1%-4.9% 
Completers 29 (35.4) 10 (45.5) 19 (31.7) 
LOCF 200 (44.3) 
116 
(43.3) 
84 (45.9) 
≥5% 
Completers 32 (39.0) 4 (18.2) 28 (46.7) 
LOCF 80 (17.7) 39 (14.6) 41 (22.4) 
Mean reduction (95% CI) in BMI 
(kg/m2) 
Completers 1.2 (0.4) 0.8 (±0.7) 1.3 (±0.4) 0.279 
LOCF 0.7 (±0.1) 0.8 (±0.2) 0.7 (±0.2) 0.474 
Mean reduction (95% CI) in waist 
circumference (cm) 
Completers 6.1 (1.4) 4.9 (±2.6) 6.5 (±1.6) 0.332 
LOCF 3.7 (±0.7) 3.4 (±1.0) 4.2 (±0.8) 0.267 
 
Between session 12 and session 155 
Mean weight loss/gain (95% CI) (kg) 0.6 (±0.8) 
-0.8 
(±1.7) 
1.2 (±0.9) 0.053 
Mean percentage weight loss/gain (95% CI) 0.8 (±0.9) 
-0.9 
(±1.7) 
1.4 (±1.1) 0.030 
 
1Among participants attending session 12 (combined n=166: GP n=75; pharmacy n=91). n=91 for pharmacy 
participants for weight loss, % weight loss and BMI owing to the erroneous recording of weight for one 
participant. 
2Last Observation Carried Forward (combined n=451: GP n=268; pharmacy n=183). n=448 (GP n=266; 
pharmacy n=182) for BMI data and n=444 (GP n=261; pharmacy n=183) for waist circumference data owing to 
missing baseline values. 
3C=Completers 
4L=LOCF 
5Among participants attending session 15 (combined n=82: GP n=22; pharmacy n=60). At session 15 n=22 for 
weight loss, % weight loss and BMI owing to the erroneous recording of weight and waist circumference for one 
participant. 
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Table 5: Costs of the My Choice Programme by provider type. Figures are in pounds sterling 
(£). 
Outcomes Combined GP Pharmacy p-value 
Breakdown of costs 
Training1 6,600 3,300 3,300 
- Initial assessments2 13,530 8,040 5,490 
Subsequent appointments3 30,070 15,630 14,440 
Total costs 50,200 26,970 23,230 - 
Costs per participant4 111.3 100.6 126.9 <0.001 
Cost per participant per session4 20.1 20.3 19.8 0.631 
Total costs per 1% of weight loss (where participants lost weight)  
Among participants attending session 125 74.3 59.0 87.0 0.042 
Among participants attending session 156 59.1 81.7 52.3 0.171 
 
1Providers were reimbursed £300 for attending two days of training upon recruitment of 6 participants 
2Providers were reimbursed £30 for the initial assessment of each participant 
3Providers were reimbursed £10 for each consultation after the initial assessment 
4Combined n=451: GP n=268; Pharmacy n=183 
5Combined n=167: GP n=75; Pharmacy n=92 
6Combined n=83: GP n=23; Pharmacy n=60 
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APPENDIX: The structure of the My Choice Weight Management Programme (NB: all 
verbal and written information provided during the programme is designed with the 
inclusion of advice, information and practical ideas specific to black and minority 
ethnic groups) 
 
Session 
number 
Topic Handouts 
0 Screening 
Issue with weigh loss raised. Check 
eligibility (BMI) and assess motivation. 
Provide an explanation of My Choice and 
gain consent. Book first appointment. 
 My Choice leaflet 
 Detailed information sheet 
 Consent form  
 Appointment card  
1 Assessment  
Welcome patient. Listen to the client and 
attempt to establish a rapport. Enquire 
about patient beliefs and their 
understanding about obesity. Gather 
information to characterise the health risks 
for the client, gaining a picture of current 
lifestyle, habits and identifying potential 
difficulties and barriers to weight loss. 
Discuss expectations and agree the way 
forward. Explain the My Choice programme. 
Measure weight and waist circumference. 
Work through the assessment sheet and 
introduce the food & activity diary. Explore 
ambivalence and assess client’s motivation. 
Assess readiness to change. Provide an 
introduction to SMART goal setting and 
identify first goals. 
 Patient record sheet (demographic and 
measurement details) for practitioners 
 My Choice Record Card for patients 
 Food and activity diary  
 Change plan (goal setting) and goal record 
card 
 Quality of Life Questionnaire 
2 Healthy Eating 
Review food & activity diary. Discuss key 
healthy eating messages and practical 
ideas for incorporating them into lifestyle.  
Discussion and support is tailored to each 
individual. Explain traffic light food guide 
and discuss alternatives for foods high in fat 
or sugar and how to reducing the fat in the 
participant’s food. Discuss healthy eating on 
a budget. Take weight and waist 
measurements. Further goal setting.  
 My Choice Healthy Eating booklet 
 Eatwell plate diagram 
 How balanced is my diet sheet.  
 Tips for adapting cultural recipes 
information. 
3-11 The order in which sessions 3-11 are delivered is tailored to the patient after discussion 
between the patient and the provider. The order the sessions are delivered in is dependent 
on which topics are the most relevant to address at the time of the appointment. 
Being More Active 
Recap on last session. Review of goals and 
goal setting. Take weight and waist 
measurements.  
 
Discuss physical activity recommendations, 
reasons to be more active, where to start 
being active, day-to-day activity, structured 
activity, walking programme and 
overcoming barriers to activity. 
 Being more active leaflet 
 Overcoming barriers worksheet 
 Relevant local activity opportunities 
information 
Planning Ahead 
Recap on last session. Review of goals and 
goal setting. Take weight and waist 
measurements.  
 Planning ahead leaflet 
 Recipe ideas 
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Provide shopping tips, cooking tips and 
meal ideas to support weight loss and 
maintenance of weight status. 
Hunger and Emotional Eating 
Recap on last session. Review of goals and 
goal setting. Take weight and waist 
measurements.  
 
Describe how to use the hunger scale. 
Discuss lifelong habits, unnecessary eating, 
triggers (particularly emotional triggers) and 
behaviour change. 
 Hunger and emotional eating leaflet 
 Behaviour chain worksheet 
 Identifying triggers worksheet 
Eating Frequency and Snacking 
Recap on last session. Review of goals and 
goal setting. Take weight and waist 
measurements.  
 
Identifying high risk situations, choosing low 
calorie snacks, difference between thirst 
and hunger. 
 Healthy snacking leaflet 
Coping with Slip Ups and Setbacks 
Recap on last session. Review of goals and 
goal setting. Take weight and waist 
measurements.  
 
Highlight that slip ups and setbacks will 
happen. Discuss practical ways to 
overcome them, staying on track, what to 
do if they do happen and examples of slip 
ups and setbacks. 
 Coping with slip ups and setbacks leaflet 
 High risk situations and strategies 
worksheet 
Portion Control 
Recap on last session. Review of goals and 
goal setting. Take weight and waist 
measurements.  
 
Provide information on recommended 
portion sizes. Assess knowledge of what a 
portion is, a standard portion size and how 
much the participant should eat daily. 
 Portion control leaflet 
Special Occasions 
Recap on last session. Review of goals and 
goal setting. Take weight and waist 
measurements.  
 
Highlight ‘damage limitation’ strategies to 
cope with the excessive consumption of 
calories centred around special occasions. 
Discuss how to get back ‘on track’ and what 
can be done before an event to minimise 
any damage to weight loss targets. 
Consider the best choices for takeaways 
and eating out. 
 Special Occasions leaflet 
Food Labelling 
Recap on last session. Review of goals and 
goal setting. Take weight and waist 
measurements.  
 
Provide information on food ingredients, 
nutritional information, daily amount 
guidance, traffic light labelling and food 
labelling claims. 
 Food labelling leaflet 
 Food labels card for shopping 
Support and Rewards 
Recap on last session. Review of goals and 
goal setting. Take weight and waist 
measurements.  
 
 Support and Rewards Leaflet 
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Brief discussion of (the benefits of) social 
support, non-food rewards, friends, family 
and practitioner support. 
Drinks 
Recap on last session. Review of goals and 
goal setting. Take weight and waist 
measurements.  
 
Outline fluid facts, alcohol facts and 
information on the calorie content of drinks. 
Offer tips to stay more hydrated. 
 Drinks leaflet 
12 Maintaining Weight Loss 
Review progress to date. Monitor weight 
and waist circumference. Discuss weight 
maintenance. Identify any potential risk of 
relapse and identify successes. Develop 
plans for self-monitoring and support. 
Complete Appointment 12 Assessment 
Sheet. Discuss how to maintain any weight 
loss achieved and how to reshape negative 
thoughts. Outline useful strategies for 
maintaining weight loss including support 
from others, coping with difficult situations, 
behaviour change and maintaining a food 
and activity diary. 
 Quality of Life Questionnaire 
 Maintaining Weight Loss leaflet 
 Reshape Negative Thoughts worksheet 
Follow up 
1 
(Patients can attend up to 3 follow up 
appointments at 2 month intervals) 
Take weight and waist circumference. 
Discuss progress and refresh on any topics 
covered during the 12 week programme. 
Set goals to help patient get back on 
track/lose further weight. 
 
Follow up 
2 
 
Follow up 
3 Quality of Life Questionnaire 
 
 
